Degrees:
2013
Doctorate Other
Bioengineering, specialised in Vaccinology
Publications resulting from Research
Rivera-Hernandez T., Walker M. Humanized Plasminogen Mouse Model to Study Group A Streptococcus Invasive Disease. In: Proft T., Loh J. (eds) Group A Streptococcus. Methods in Molecular Biology, vol 2136. Humana, New York, NY, 2020.
Xu Z., Rivera-Hernandez T., Moyle P. Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein–Fusion Combination Vaccine. ACS Infectious Diseases, 6, 7, 1770–1782, 2020.
Rivera-Hernandez T., Rhyme M. S., Cork A. J., Jones S., Segui-Perez C., Brunner L., Richter J., Petrovsky N., Lawrenz M., Goldblatt D., Collin N., Walker M. J. Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies. mBio 11 (2), 2020.
Rivera-Hernandez T., Carnathan D. G., Jones S., Cork A. J., Davies M. R., Moyle P., Toth I., Batzloff M. R., McCarthy J., Nizet V., Goldblatt D., Silvestri G., Walker M. J. An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model. mBio 10 (2), 2019.
Rivera-Hernandez T., Pandey M., Henningham A., Cole J., Choudhury B., Cork A. J., Gillen C. M., Ghaffar K. A., West N. P., Silvestri G., Good M. F., Moyle P. M., Toth I., Nizet V., Batzloff M. R., Walker M. J. Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models. mBio 7(3), 2016.
Barnett T.C., Cole J.N., Rivera‐Hernandez T., Henningham A., Paton J.C., Nizet V., Walker M.J. Streptococcal toxins: role in pathogenesis and disease. Cellular microbiology 17 (12), 2015.
Rivera-Hernandez T., Carnathan D. G., Moyle P., Toth I., West N. P., Young P. R., Silvestri G., Walker M. J. The contribution of non-human primate models to the development of human vaccines. Discovery Medicine 18(101), 2014.
Chuan, Y.P., Rivera-Hernandez, T., Wibowo, N., Connors, N.K.,Wu, Y., Hughes, F.K., Lua, L.H., Middelberg, A.P. Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine. Biotechnology and Bioengineering 110 (9) 2013.
Rivera-Hernandez, T., Hartas, J., Wu, Y., Chuan, Y.P., Lua, L.H.L., Good, M., Batzloff, M.R., Middelberg, A.P.J. Self-adjuvanting modular virus-like particles for mucosal vaccination against group A Streptococcus (GAS). Vaccine 31 (15) 2013.
Middelberg, A.P.J., Rivera-Hernandez, T., Wibowo, N., Lua, L.H.L., Fan, Y., Magor, G., Chang, C., Chuan, Y.P., Good, M., Batzloff, M.R. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine 29 (41), September 2011, pp. 7154-7162.
Lorne Infection and Immunity Conference
2025
Australia20th Lancefield International Symposium on Streptococci and Streptococcal Diseases
2025
FijiVaccinology course
2025
Institut Pasteur, Paris FranceLorne Infection and Immunity Conference
2025
Australia20th Lancefield International Symposium on Streptococci and Streptococcal Diseases
2025
FijiBactiVac Annual Meeting
2025
Birmingham, UK